Brief: Adagene Announces Presentations Of Data For Two Antibody Programs At ESMO Immuno-Oncology Congress 2021
22/11/2021 22:16
Nov 22 (Reuters) - Adagene Inc 978y.F :
* ADAGENE ANNOUNCES POSTER PRESENTATIONS OF CLINICAL DATA
FOR TWO
NOVEL ANTIBODY PROGRAMS AT ESMO IMMUNO-ONCOLOGY CONGRESS 2021
Source text for Eikon: ID:nGNX1j8V2T
Further company coverage: 978y.F
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Adagene
See all newsBrief: Adagene Inc Announces Offering Of American Depositary Shares
Brief: Adagene Announces FDA Fast Track Designation For Muzastotug (Adg126)
Brief: Adagene Expands SAFEBody Deal With Exelixis To Develop Third Novel Masked Antibody-Drug Conjugate
Brief: Adagene Inc - Partners With Conjugatebio For Antibody Drug Conjugate Development
Brief: Adagene Announces Up To $25 Million Strategic Investment From Sanofi